Drug Information

Drug General Information
Drug ID
D0H2UM
Former ID
DNC005027
Drug Name
2-(5-Bromo-indole-1-sulfonyl)-benzoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527208]
Formula
C15H10BrNO4S
Canonical SMILES
C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)N2C=CC3=C2C=CC(=C3)Br
InChI
1S/C15H10BrNO4S/c16-11-5-6-13-10(9-11)7-8-17(13)22(20,21)14-4-2-1-3-12(14)15(18)19/h1-9H,(H,18,19)
InChIKey
RGZDWZUMVMDEAG-UHFFFAOYSA-N
PubChem Compound ID
44393643
Target and Pathway
Target(s) Fatty acid-binding protein, adipocyte Target Info Inhibitor [527208]
KEGG Pathway PPAR signaling pathway
NetPath Pathway TCR Signaling Pathway
Pathway Interaction Database AP-1 transcription factor network
Reactome Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
Transcriptional regulation of white adipocyte differentiation
WikiPathways Lipid digestion, mobilization, and transport
Transcriptional Regulation of White Adipocyte Differentiation
References
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.